Athersys (ATHX) Competitors

Vaxxinity (NASDAQ:VAXX) and Athersys (NASDAQ:ATHX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

Is VAXX or ATHX more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Vaxxinity	N/A	N/A	N/A
Athersys	N/A	N/A	-223.03%

Do institutionals & insiders believe in VAXX or ATHX?

82.9% of Vaxxinity shares are owned by institutional investors. Comparatively, 19.4% of Athersys shares are owned by institutional investors. 64.1% of Vaxxinity shares are owned by company insiders. Comparatively, 0.0% of Athersys shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Which has preferable earnings & valuation, VAXX or ATHX?

Vaxxinity has higher earnings, but lower revenue than Athersys. Vaxxinity is trading at a lower price-to-earnings ratio than Athersys, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vaxxinity	N/A	N/A	-$56.93M	-$0.45	-0.10
Athersys	$146K	0.00	-$72.53M	-$2.03	N/A

Does the media favor VAXX or ATHX?

In the previous week, Vaxxinity's average media sentiment score of 0.00 equaled Athersys'average media sentiment score.

Company	Overall Sentiment
Vaxxinity	Neutral
Athersys	Neutral

Which has more risk and volatility, VAXX or ATHX?

Vaxxinity has a beta of -24.16, indicating that its share price is 2,516% less volatile than the S&P 500. Comparatively, Athersys has a beta of -0.9, indicating that its share price is 190% less volatile than the S&P 500.

Summary

Vaxxinity beats Athersys on 5 of the 8 factors compared between the two stocks.